397PMetabolic and myogenic defects as a therapeutic target in type 1 myotonic dystrophy (DM1). - Lessard, L.; Larbi, S. Ben; Weiss-Gayet, M.; Courchet, J.; Furling, D.; Gallay, L.; Mounier, R. (Neuromuscular Disorders, 2025)